Rezera (formerly NodThera)

NodThera

The company develops oral small molecule inhibitors for inflammatory diseases to treat patients with cardiovascular, neurological and metabolic conditions.

Therini Bio

The company develops fibrin-targeting monoclonal antibodies to treat patients with neurodegenerative and retinal diseases caused by vascular-mediated inflammation.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.

PsiThera

PsiThera develops oral small-molecule medicines for patients with immune and inflammatory diseases, using a physics-driven platform to target proteins traditionally requiring injections.

Revier Therapeutics

This company develops orally available small molecules targeting class IIa histone deacetylases to treat patients with heart failure and atherosclerotic cardiovascular diseases.

Noara Therapeutics

This company engineers stable and immunosilent ribonucleic acid therapies using machine intelligence to treat patients with chronic and complex diseases.

UPPTHERA

The company develops targeted protein degradation therapies for patients with cancer and rare diseases and provides platform technologies to pharmaceutical and biotechnology companies.

Resolution Therapeutics

Resolution Therapeutics develops macrophage cell therapies to treat patients with inflammatory and fibrotic diseases such as end-stage liver disease.